Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

BACKGROUND/AIMS: Angiotensin-converting enzyme 2 (ACE2), its product, angiotensin-(1–7) and its receptor, Mas, may moderate the adverse effects of angiotensin II in liver disease. We examined the expression of these novel components of the renin angiotensin system (RAS) and the production and vasoac...

Descripción completa

Detalles Bibliográficos
Autores principales: Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114685/
https://www.ncbi.nlm.nih.gov/pubmed/17532087
http://dx.doi.org/10.1016/j.jhep.2007.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114685/
https://www.ncbi.nlm.nih.gov/pubmed/17532087
http://dx.doi.org/10.1016/j.jhep.2007.03.008

Ejemplares similares